Jhunjhunwala family-backed IKS Health acquires U.S. health-tech firm for ₹1,600 cr; plans IPO by Q4 FY24
The company will fund the acquisition by raising ₹1,000 crore from three global banks, and the remaining ₹600 crore from internal accruals.
The company will fund the acquisition by raising ₹1,000 crore from three global banks, and the remaining ₹600 crore from internal accruals.
Rakesh Jhunjhunwala had an estimated net worth of ₹31,905 crore (as of July 2022) and his biggest investment was in Titan Company, Star Health, and Metro Brands
The “big bull” was showered with questions on investing by women who seemed to think anything Jhunjhunwala touched would turn into gold at a recent event.